Edition:
United States

ESSA Pharma Inc (EPIX.OQ)

EPIX.OQ on NASDAQ Stock Exchange Capital Market

4.02USD
10:52am EDT
Change (% chg)

$0.42 (+11.67%)
Prev Close
$3.60
Open
$3.59
Day's High
$4.40
Day's Low
$3.58
Volume
4,312
Avg. Vol
2,176
52-wk High
$51.00
52-wk Low
$2.78

Select another date:

Tue, Mar 6 2018

BRIEF-Essa Pharma Files For Resale Of 113.9 Mln Common Shares By Selling Shareholders

* ESSA PHARMA INC FILES FOR RESALE OF CO'S 113.9 MILLION COMMON SHARES BY SELLING SHAREHOLDERS - SEC FILING Source: (http://bit.ly/2Ft0Xh1) Further company coverage:

BRIEF-Essa Pharma Qtrly Loss Per Share $0.07

* ESSA PHARMA PROVIDES CORPORATE UPDATE AND REPORTS FINANCIAL RESULTS FOR FISCAL FIRST QUARTER ENDED DECEMBER 31, 2017

BRIEF-Essa Pharma Files For Offering Of About 113.9 Million Common Shares That May Be Offered For Resale By Selling Shareholders

* ESSA PHARMA INC FILES FOR OFFERING OF ABOUT 113.9 MILLION COMMON SHARES THAT MAY BE OFFERED FOR RESALE BY SELLING SHAREHOLDERS - SEC FILING Source text: (http://bit.ly/2Dsiula) Further company coverage:

BRIEF-Bvf Partners Reports 9.9 Percent Passive Stake In Essa Pharma‍​

* BVF PARTNERS L.P REPORTS 9.9 PERCENT PASSIVE STAKE IN ESSA PHARMA INC AS OF JANUARY 5, 2018 - SEC FILING ‍​ Source text - http://bit.ly/2DgNTLE Further company coverage:

BRIEF-Essa Says Intends To Issue Up To 125 Mln Common Shares At $0.20 Per Share

* ESSA ANNOUNCES FILING OF AMENDED AND RESTATED PROSPECTUS SUPPLEMENT AND AN UPDATE TO PREVIOUSLY ANNOUNCED EQUITY OFFERING

BRIEF-Essa Pharma Announces Pricing Of Previously Announced Equity Offering

* ESSA PHARMA ANNOUNCES PRICING OF PREVIOUSLY ANNOUNCED EQUITY OFFERING

BRIEF-ESSA Pharma announces overnight marketed equity offering

* ESSA PHARMA - TO USE NET PROCEEDS OF OFFERING PRIMARILY TO CONTINUE ONGOING PRECLINICAL DEVELOPMENT OF CO'S ANITEN COMPOUNDS Source text for Eikon: Further company coverage:

BRIEF-Essa Pharma Reports Qtrly Loss Per Share Of $0.07

* ESSA PHARMA ANNOUNCES FINANCIAL RESULTS FOR THE FISCAL FOURTH QUARTER AND YEAR ENDED SEPTEMBER 30, 2017

Select another date: